Skip navigation
Skip navigation

Endometrial cancer and hormone replacement therapy in the Million Women Study

Banks, Emily

Description

Background: Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alone are at increased risk of endometrial cancer. To minimise this risk, many HRT users who have not had a hysterectomy use combined oestrogen-progestagen preparations or tibolone. Limited information is available on the incidence of endometrial cancer in users of these therapies. Methods: 716 738 postmenopausal women in the UK without previous cancer or previous hysterectomy were recruited into the...[Show more]

CollectionsANU Research Publications
Date published: 2005
Type: Journal article
URI: http://hdl.handle.net/1885/83293
Source: Lancet, The (UK edition)
DOI: 10.1016/S0140-6736(05)66455-0

Download

File Description SizeFormat Image
01_Banks_Endometrial_cancer_and_hormone_2005.pdf117.54 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  12 November 2018/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator